Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-22

Clinical Trial Update: Benefits of Nicotinamide Riboside Upon Cognition and Sleep [NA]

View source ↗

Summary

The clinical trial investigates nicotinamide riboside for cognition and sleep outcomes. It is currently recruiting at the State University of New York at Buffal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Cognitive Impairment, Sleep Quality | NA | Status: RECRUITING